Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Long

Showing results (81-90 of 108) with videos related to

Pageof 11
Sort By:
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|October 21, 2009
The feasibility of using an 'opt-out' approach to achieve universal HIV testing of tuberculosis patients in AlbertaDoris Sturtevant, Jutta Preiksaitis, Ameeta Singh, et al.
BMC Medicine|August 9, 2018
Epidemiological and genomic determinants of tuberculosis outbreaks in First Nations communities in CanadaAlexander Doroshenko, Caitlin S Pepperell, Courtney Heffernan, et al.
Open Forum Infectious Diseases|September 22, 2025
Costs of 4 Months of Rifampin Versus 2 Months of Double-dose Rifampin for Tuberculosis Infection: Post-Hoc Analysis of a Phase 2b Randomized TrialKamila Romanowski, Yen Pham Ngoc, Leila Barss, et al.
The Journal of Infection|December 17, 2023
The association between phylogenetic lineage and the subclinical phenotype of pulmonary tuberculosis: A retrospective 2-cohort studyRichard Long, Matthew Croxen, Robyn Lee, et al.
Canadian Respiratory Journal|May 30, 2013
Marked disparity in the epidemiology of tuberculosis among Aboriginal peoples on the Canadian prairies: the challenges and opportunitiesRichard Long, Vernon Hoeppner, Pamela Orr, et al.
Annals of Internal Medicine|November 20, 2008
Adverse events with 4 months of rifampin therapy or 9 months of isoniazid therapy for latent tuberculosis infection: a randomized trialDick Menzies, Richard Long, Anete Trajman, et al.
The Journal of Infectious Diseases|March 8, 2024
Characterization of Mycobacterium orygis, Mycobacterium bovis, and Mycobacterium caprae Infections in Humans in Western CanadaNicholas D Riopel, Richard Long, Courtney Heffernan, et al.
American Journal of Obstetrics and Gynecology|December 17, 2008
The clinical content of preconception care: immunizations as part of preconception careDean V Coonrod, Brian W Jack, Kim A Boggess, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 22, 2025
Impact of the COVID-19 pandemic on tuberculosis program performance in Alberta, Canada: a population-based evaluationSeun Akinfolarin, Divya Shah, Courtney Heffernan, et al.
Chest|February 5, 2022
The Radiographic and Mycobacteriologic Correlates of Subclinical Pulmonary TB in Canada: A Retrospective Cohort StudyAngela Lau, Christopher Lin, James Barrie, et al.
Pageof 11

Showing results (81-90 of 108) with videos related to

Sort By:
Pageof 11
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|October 21, 2009
The feasibility of using an 'opt-out' approach to achieve universal HIV testing of tuberculosis patients in AlbertaDoris Sturtevant, Jutta Preiksaitis, Ameeta Singh, et al.
BMC Medicine|August 9, 2018
Epidemiological and genomic determinants of tuberculosis outbreaks in First Nations communities in CanadaAlexander Doroshenko, Caitlin S Pepperell, Courtney Heffernan, et al.
Open Forum Infectious Diseases|September 22, 2025
Costs of 4 Months of Rifampin Versus 2 Months of Double-dose Rifampin for Tuberculosis Infection: Post-Hoc Analysis of a Phase 2b Randomized TrialKamila Romanowski, Yen Pham Ngoc, Leila Barss, et al.
The Journal of Infection|December 17, 2023
The association between phylogenetic lineage and the subclinical phenotype of pulmonary tuberculosis: A retrospective 2-cohort studyRichard Long, Matthew Croxen, Robyn Lee, et al.
Canadian Respiratory Journal|May 30, 2013
Marked disparity in the epidemiology of tuberculosis among Aboriginal peoples on the Canadian prairies: the challenges and opportunitiesRichard Long, Vernon Hoeppner, Pamela Orr, et al.
Annals of Internal Medicine|November 20, 2008
Adverse events with 4 months of rifampin therapy or 9 months of isoniazid therapy for latent tuberculosis infection: a randomized trialDick Menzies, Richard Long, Anete Trajman, et al.
The Journal of Infectious Diseases|March 8, 2024
Characterization of Mycobacterium orygis, Mycobacterium bovis, and Mycobacterium caprae Infections in Humans in Western CanadaNicholas D Riopel, Richard Long, Courtney Heffernan, et al.
American Journal of Obstetrics and Gynecology|December 17, 2008
The clinical content of preconception care: immunizations as part of preconception careDean V Coonrod, Brian W Jack, Kim A Boggess, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 22, 2025
Impact of the COVID-19 pandemic on tuberculosis program performance in Alberta, Canada: a population-based evaluationSeun Akinfolarin, Divya Shah, Courtney Heffernan, et al.
Chest|February 5, 2022
The Radiographic and Mycobacteriologic Correlates of Subclinical Pulmonary TB in Canada: A Retrospective Cohort StudyAngela Lau, Christopher Lin, James Barrie, et al.
Pageof 11